Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
31 studies found for:    " November 14, 2012":" December 14, 2012"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
RSS Create an RSS feed from your search for:
" November 14, 2012":" December 14, 2012"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed An Evaluation of a Rapid Test for HIV
Condition: HIV Seropositivity
Intervention: Device: Rapid testing for HIV
2 Completed Project ACCEPT: Engaging Newly Diagnosed HIV+ Youth in Care
Condition: HIV Positive Youth That Are Newly Engaged in Care
Interventions: Behavioral: Project ACCEPT;   Behavioral: HEALTH
3 Withdrawn The Feasibility of Using a General Health Screen to Increase HIV Testing in Community Pharmacies
Condition: HIV Infections
Interventions: Behavioral: HIV Test Offer;   Behavioral: General Health Screen Offer
4 Terminated Safety and Efficacy of (α1Proteinase Inhibitor, α1PI) in HIV Disease
Condition: HIV Disease
Intervention: Biological: α1 Proteinase Inhibitor
5 Completed Vitamin D Absorption in HIV Infected Young Adults Being Treated With Tenofovir Containing cART
Condition: HIV Infection
Interventions: Dietary Supplement: Vitamin D3 50,000 IU;   Dietary Supplement: Vitamin D3 placebo
6 Completed Interaction Between Etravirine or Darunavir/Ritonavir and Artemether / Lumefantrine
Condition: HIV
Interventions: Drug: Etravirine;   Drug: Darunavir/ritonavir;   Drug: artemether/lumefantrine
7 Active, not recruiting Safety Study of a Dual Anti-HIV Gene Transfer Construct to Treat HIV-1 Infection
Condition: Human Immunodeficiency Virus
Interventions: Drug: Busulfan;   Biological: Cal-1 modified HSPC;   Biological: Cal-1 modified CD4+ T lymphocytes
8 Recruiting Evaluating the Safety, Tolerance, and Pharmacokinetics of a Raltegravir-Containing Antiretroviral Therapy (ART) Regimen in Children Infected With HIV and TB
Conditions: HIV Infections;   Tuberculosis
Intervention: Drug: Raltegravir
9 Unknown  Efficacy of Antifolates Against Malaria in HIV-infected Pregnant Women and the Emergence of Induced Resistance in Plasmodium Falciparum
Conditions: Malaria in Pregnancy;   HIV Infection
Interventions: Drug: cotrimoxazole daily prophylaxis;   Drug: sulphadoxine-pyrimethamine
10 Recruiting Neurocognitive Effects of Opiate Agonist Treatment
Conditions: Opioid-Related Disorders;   HIV;   HIV Infections
Interventions: Drug: Buprenorphine;   Drug: Methadone
11 Completed Veterans Living With HIV/AIDS: A Pilot Study Examining Risk Factors Associated With Self-Directed Violence
Conditions: Human Immunodeficiency Virus Infection(HIV)/Acquired Immunodeficiency Syndrome (AIDS);   Self-Directed Violence
Intervention:
12 Completed A Post Marketing Survey Study to Evaluate the Safety and Effectiveness of Intelence
Condition: Acquired Immune Deficiency Syndrome
Intervention: Drug: No intervention
13 Active, not recruiting A Post Marketing Survey Study to Evaluate the Safety and Effectiveness of Prezista
Condition: Acquired Immune Deficiency Syndrome
Intervention: Drug: No intervention
14 Unknown  A Phase IV, Open-label Single-arm Study Investigating the Pharmacokinetics and Pharmacodynamics of the Antiretroviral Combination of Rilpivirine and Ritonavirboosted Darunavir in Therapy-naive HIV-1 Infected Patients.
Condition: HIV
Intervention: Drug: Darunavir, Ritonavir and Rilpivirine
15 Completed DDI Potential: Dapivirine Vaginal Ring and Miconazole Nitrate
Condition: HIV
Interventions: Drug: dapivirine;   Drug: miconazole
16 Unknown  Assessment of Cognitive Functioning as it Relates to Risk for Suicide in Veterans With HIV/AIDS
Condition: Veterans With HIV/AIDS Diagnosis.
Intervention:
17 Recruiting Does Rosuvastatin Delay Progression of Atherosclerosis in HIV
Conditions: HIV;   Cardiovascular Disease
Interventions: Drug: Rosuvastatin;   Other: Placebo
18 Withdrawn A Safety and Efficacy Study of Amdoxovir in HIV-1 Treatment-experienced Subjects
Condition: Human Immunodeficiency Virus Infection
Interventions: Drug: amdoxovir 300 mg bid;   Drug: amdoxovir 500 mg bid
19 Completed Tenofovir Levels Following Local Application of Tenofovir Reduced-Glycerin 1% Gel
Condition: HIV Prevention
Interventions: Drug: Once Daily Application of TFV RG 1% Gel;   Drug: Once Daily Application of TFV RG 1% gel - Rectal;   Drug: Once Daily Application of TFV RG 1% Gel - Vaginal
20 Completed
Has Results
Atorvastatin for HAART Suboptimal Responders
Condition: Acquired Immune Deficiency Syndrome Virus
Interventions: Other: atorvastatin, Lipitor®;   Drug: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-31) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.